Date:October 11, 2026
For generations, many of the world’s most advanced biologic medicines have been developed and manufactured far from Africa.
But what if Africa could build the capability to discover, develop, manufacture, and deliver its own life-changing biologics?
What if world-class biomanufacturing could be built on the continent — creating local expertise, strengthening health systems, and bringing critical therapies closer to the patients who need them?
At Bio Usawa, we believe that future is within reach.
In Rwanda, we are turning that belief into reality with the first monoclonal antibody manufacturing facility in Sub-Saharan Africa; a bold step toward a stronger, more self-sustaining African biopharmaceutical ecosystem.
This is where the journey begins. Dare to imagine. Then build it.
Bio Usawa this week welcomed Dr. Yvan Butera, Rwanda’s Minister of State for Health, to its biomanufacturing facility in Kigali, where he was received b…
November 2026As African health authorities strengthen preparedness against Ebola and other emerging health threats, a persistent challenge remains. The continent is …
October 2026Bio Usawa is proud to celebrate Dr. Aida Habtezion, a member of our Board of Directors, on her new role as a Global Health Faculty Fellow at the Stanfor…
October 2026